IRS2 and colonic neoplasm: In summary, our work identifies EKR-mediated Mcl-1 stabilization via feedback activation of S6K1-IRS-2/PI3K as a novel resistance mechanism to mTOR inhibitors in BRAF600E colon cancer cells.